Nope [Two-Stage / GS Designs]

posted by nobody – 2017-11-14 08:11 (1106 d 11:27 ago) – Posting: # 17978
Views: 6,554

IANAL, but I think what San-Diego-man is proposing is to calculate BE-outcome (pass/fail) after stage 1 and compare it to BE-outcome after the (unnecessary) second stage for, let's say, 1 gazillion of studies and see if there is a meaningful difference.

Isn't this a special example of the more general "forced BE" theme in one-stage designs?

Kindest regards, nobody

Complete thread:

 Admin contact
21,206 posts in 4,425 threads, 1,481 registered users;
online 5 (0 registered, 5 guests [including 4 identified bots]).
Forum time: Tuesday 19:38 CET (Europe/Vienna)

All we know about the world teaches us that the effects of A and B
are always different—in some decimal place—for any A and B.
Thus asking “are the effects different?” is foolish.    John W. Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz